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This s t u d y i nv e s t i g a t e d t h e p o s s i b i l i t y t h a t t h e o p h y l l i n e , a s commonly used f o r asthma therapy, might a l s o i n h i b i t mediator r e l e a s e . 7 a t o p i c s u b j e c t s (6 a s t h m a t i c c h i l d r e n and an a d u l t w i t h hayfever)
had leukocyte h i s t a m i n e r e l e a s e determined w i t h ant i g e n s t o which they were s e n s i t i v e . Release was measured a t 8 a.m. and 1 2 noon on 2 c o n t r o l days and on a drug day, on which t h e o p h y l l i n e 6mg/kg was given o r a l l y a t 8 a.m. Plasma t h e o p h y l l i n e l e v e l s were determined on each specimen of blood drawn f o r h i s t a m i n e r e l e a s e . 3 s u b j e c t s had up t o 38% i n h i b it i o n o f histamine r e l e a s e by t h e o p h y l l i n e ; t h e o t h e r 4 pat i e n t s showed no e f f e c t . 2 of t h e 3 s u b j e c t s who showed i n h ib i t i o n had plasma t h e o p h y l l i n e l e v e l s i n excess of 10pg/ml; a l l of t h e unresponsive s u b j e c t s had l e v e l s l e s s than 10,ug/ml. The plasma l e v e l achieved by a g i v e n dose of t h e o p h y l l i n e i s extremely v a r i a b l e among p a t i e n t s , but i n some p a t i e n t s leve l s a r e achieved which w i l l i n h i b i t mediator r e l e a s e . This s u g g e s t s t h a t i n some a s t h m a t i c c h i l d r e n t h e o p h y l l i n e may have b e n e f i c i a l e f f e c t s o t h e r t h a n bronchodilatation.
RELATIONSHIP BETWEEN DOSE AND APPARENT VOLUME OF DISTRIBUTION OF SALICYLATE I N CHILDREN. Gerhard Levy and Sumner J . Yaffe, Departments of Pharmaceutics and P e d i a t r i c s , S t a t e U n i v e r s i t y of New York a t Buffalo.
The purpose of t h i s i n v e s t i g a t i o n was t o determine the r e l a t i o n s h i p between dose and t h e d i s t r i b u t i o n of s a l i c y l a t e i n t h e body. The apparent volume of d i s t r i b u t i o n was determined from t h e c o n c e n t r a t i o n of s a l i c y l a t e i n plasma o r serum a t v a r i o u s times a f t e r s a l i c y l a t e i n g e s t i o n and from t h e amount of d r u g remaining i n t h e body a t t h e s e times a s a s s e s s e d from u r i n a r y e x c r e t i o n d a t a . These s t u d i e s were c a r r i e d o u t on eleven c h i l d r e n , 4 months t o 16 y e a r s o l d , who had ingested from about 36 t o over 340 mg. s a l i c y l i c acid (mainly a s a s p i r i n ) per kg. of body weight. The apparent volume of d i s t r i b u t i o n of s a l i c y l a t e ranged from 162 t o 345 ml./kg. and increased w i t h i n c r e a s i n g dose. This means t h a t plasma s a l i c y l a t e c o n c e n t r a t i o n s i n c h i l d r e n who have ingested l a r g e doses of t h e drug a r e p r o p o r t i o n a t e l y not a s high a s those i n c h i l d r e n who i n g e s t e d lower doses of s a l i c y l a t e . These o b s e r v a t i o n s h e l p t o r a t i o n a l i z e t h e use of t h e Done nomogram (which involves e s t i m a t i o n of i n i t i a l s a l i c y l a t e c o n c e n t r a t i o n s by back e x t r a p o l a t i o n ) t o a s s e s s t h e s e v e r i t y of s a l i c y l a t e i n t o x i c a t i o n on the b a s i s of plasma s a l i c y l a t e c o n c e n t r a t i o n s .
(Supported i n p a r t by g r a n t s ~~1 9 5 6 8 and RR-628 from the National I n s t i t u t e s of ~e a l t h ) We have shown p r e v i o u s l y t 6 a t n i c o t i n e r e a d i l y crosses t h e r a t placenta. The present experiments were undertaken t o determine whether n i c o t i n e causes catecholamine r e l e a s e by t h e f e a t r a t adrenal, and whether acute o r chronic dosage o f t h e f e t u s w i t h n i c o t i n e causes l i p i d increases i n f e t a l plasma. Pregnant Long-Evans r a t s were f e d stock d i e t s c o n t a i n i n g 0.05 o r 0.1 mg/g added n i c o t i n e d u r i n g 10-20 o r 0-20 d o f pregnancy. Control r a t s were f e d stock d i e t d u r i n g 0-20 d. Mean n i c o t i n e i n t a k e ranged up t o 6.03 nig/kg/d. No s i g n i f i c a n t changes occurred i n f e t a l plasma on day 20 w i t h r e s p e c t t o t r i g l y c e r i d e (TG), P -l i p i d o r c h o l e s t e r o l l e v e l s . Pregnant r a t s were g i v e n s i n g l e doses o f 1 mg/kg n i c o t i n e i p on day 20. Maternal plasva f r e e f a t t y acids (FFA) and TG rose, b u t f e t a l values d i d n o t change. F e t a l adrenal E content decreased a f t e r n i c o t i n e i n j e c t i o n and then r o s e t o s l i g h t l y higher than c o n t r o l values. There was no decrease a f t e r s a l i n e i n j e c t i o n . The r e s u l t s i n d i c a t e t h a t t h e f e t a l adrenal o f t h e r a t sec r e t e s E i n response t o n i c o t i n e e n t e r i n g t h e f e t u s t r a n sp l a c e n t a l l y . The r e s i s t a n c e o f f e t a l FFF t o change a f t e r n i co t i n e i s probably due t o r e s i s t a n c e t o E induced e l e v a t i o n o f FFA. The placenta may be r e s p o n s i b l e f o r m a i n t a i n i n g t h e steady s t a t e o f f e t a l plasma l i p i d s .
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LIPOLYTIC ACTION OF L-CARNITINE I N VITRO IN HUMAN NEWBORN
SUBCUTANEOUS ADIPOSE TISSUE. Milan Novak*, Duns Penn-Walker and E l l e n Monkus, Dept. of Ped., Univ. of Miami Sch. of Med., Miami, Fla.
Oxidation of f a t t y a c i d s i s a major pathway supporting energy r e q u i r i n g processes i n t h e e a r l y p o s t n a t a l period. This i s documented by an i n c r e a s e i n f r e e f a t t y a c i d s (FFA), g l y ce r o l and ketone bodies i n t h e blood. FFA and g l y c e r o l a r i s e from i n t e n s i v e t r i g l y c e r i d e breakdown i n white adipose t i s s u e .
Activation of l i p o l y s i s r e q u i r e s ATP. Decreased l i p o l y s i s i s seen i n v i t r o a f t e r t h e f i r s t 24-48 h r of l i f e . Since FFA can uncouple mitochondria1 r e s p i r a t i o n , t h e e a r l y accumulation of FFA known t o occur i n adipose t i s s u e could l e a d t o a secondary depression of l i p o l y s i s due t o inadequate ATP generation.
C a r n i t i n e a c t s as a coupling agent i n mammalian brown f a t mitochondria. I t s e f f e c t on l i p o l y s i s ( g l y c e r o l r e l e a s e ) was measured i n fragments of human newborn and a d u l t subcutaneous (white) adipose t i s s u e . I n t h e neonate, L -c a r n i t i n e (2.5mM) enhanced g l y c e r o l r e l e a s e w i t h o r without s t i m u l a t i o n by a phosphodiesterase i n h i b i t o r ( t h e o p h y l l i n e , ~o -~M ) o r a betaagonis t ( i s o p r o t e r e n o l , 10-~?$(~60.05) ; d e o x y c a r n i t i n e (2.5mM) decreased l i p o l y s i s under s i m i l a r c o n d i t i o n s (fi0.05).
I n t h e a d u l t , L -c a r n i t i n e increased l i p o l y s i s only i n presence of i s o p r o t e r e n o l (pL0.05) while deoxycarqitine had no e f f e c t .
C a r n i t i n e i s contained i n milk. These s t u d i e s suggest a d e f i c i e n c y of c a r n i t i n e might decrease t h e a v a i l a b i l i t y of FFA as f u e l f o r e s s e n t i a l metabolic needs, p a r t i c u l a r l y i n t h e small o r ill neonate w i t h inadequate o r a l i n t a k e .
A STUDY OF FACTORS THAT INFLUENCE THE SEVERITYOFNEONATAL NAR-COTIC WITHDRAWAL. E.M.Ostrea,Jr., C.J. Chavez & M.E. S t r a u s s Wayne S t a t e Univ., u t z e osp.
Chx r e d s osp. o i c e p t s Peds.. & Psychol., Dztroi:,\ichiEan.
'FIntr. : y P.V.::lI%$,?Jr.)
A p r o s p e c t i v e study of 198 i n f a n t s of d r u g d e endent mothers included: (1) h i s t o r y of maternal drugl h a b i t $2y measurement i n infanr's u r i n e of t o t a l morphine& ua i t a t l 4 e e t e c t i o n of o t h e r drugs b gas chromatograph q3) e v a l u a t i o n of s e v e r i t of n e o n a t a l withzrawal by a scoring'system& 4)stud of theefi?ect of a modified environment ( q u i e t , warm, dim\y l i t hlfrequent feeding) on withdrawal.
RESULTS: ( 1 ) h i s t o r y i s u n r e l i a b l e i n a s s e s s i n g m a t e r n a l d r u g hablc. f l e a n x o r p h i n e l e v e l s of 1.02 & 0.99 mg%were found i n t h e u r i n e of i n f a n t s whose mothers claimnon-usageof h e r o i n f o r 1-3 months b e f o r e d e l i v e r r e s p e c t i v e l y (2 s e v e r i t y of n e o n a t a l withdrawal d i d n o t c o r r e y i t e w i t h i n i a i t ' d r i n e mor h i n e l e v e l (range0-9 4mg"/P ( . of moderate withdrawal 277 (C) v s 267 (E). of s e v e r e wikhd;awal' 57 (C) vs. 37 (E The d i f f e r e n c e detwlen t h e 2 groups was n a t s i i n i % i c a q t . (<) t k e p u a l l t a t l v e detection of o t h e r drugs i n the ~n f a n t s uflne wi 1 b e presented.
EFFECT OF ALBUMIN AND DRUG CONCENTRATION O N THE BINDING OF FUROSEMIDE. Jozef Prandota and A l b e r t W. P r u i t t , ( I n t r . by R.W. Blumberg), Emory U n i v e r s i t y School of Medicine, Department of P e d i a t r i c s and C l i n i c a l Pharmacology Program, A t l a n t a .
Furosemide i s 95% bound t o human plasma (Kelly, e t a l . , Clin. Res. 21:199, 1973) ; however, f a c t o r s i n f l u e n c i n g t h a t binding have not been evaluated.
The binding of furosemide14c (carboxyl-14c) t o human albumin and plasma was i n v e s t igated by e q u i l i b r i u m d i a l y s i s a t 3 7 '~ f o r 18-24 hours. Bindi n g of furosemide (3.4 uglml) t o varying c o n c e n t r a t i o n s of human albumin decreased s l i g h t l y from 97.2% (5 gm% albumin) t o 95.8% (2 gm%). However, albumin c o n c e n t r a t i o n s l e s s than t h i s showed a g r e a t e r decrease i n binding t o 89.6% (0.5 gm% albumin). Using 4 gm% human albumin, binding of t h e drug decreased from 97% t o 89% a s furosemide c o n c e n t r a t i o n was increased from 1.8 uglml t o 600 uglml. Furosemide (4 ug/ml) was not d i s p l a c e d by diphenylhydantoin, p h e n o b a r b i t a l , diazoxide, trif l u o p e r a z i n e o r chloramphenicol i n t h e r a p e u t i c c o n c e n t r a t i o n s .
Influence of albumin c o n c e n t r a t i o n on t h e binding of f u r osemide was evaluated i n plasma from 3 c h i l d r e n w i t h n e p h r o t i c syndrome. The albumin c o n c e n t r a t i o n was 0.6, 1.1 and 1.8 gm% and t h e r e s p e c t i v e binding of furosemide was 93, 90 and 95%. These f i n d i n g s demonstrate t h a t t h i s d i u r e t i c i s h i g h l y bound t o plasma albumin, and t h e f r e e drug f r a c t i o n may be a f f e c t e d by both the dose and t h e p a t i e n t ' s plasma albumin concentration.
